Xifaxan (rifaximin)
Hepatic Encephalopathy
Key Facts
About Bausch Health
Bausch Health Companies Inc. is a multinational company dedicated to improving people's lives through its portfolio of pharmaceutical, medical device, and over-the-counter products. Its strategy revolves around its core therapeutic areas, leveraging a mix of in-house R&D and strategic acquisitions, most notably the Bausch + Lomb eye health business. The company is executing a turnaround plan focused on debt reduction, portfolio optimization, and growth in key segments like gastroenterology and aesthetics to drive long-term shareholder value.
View full company profileAbout Bausch Health
Bausch Health Companies Inc. is a multinational company dedicated to improving people's lives through its portfolio of pharmaceutical, medical device, and over-the-counter products. Its strategy revolves around its core therapeutic areas, leveraging a mix of in-house R&D and strategic acquisitions, most notably the Bausch + Lomb eye health business. The company is executing a turnaround plan focused on debt reduction, portfolio optimization, and growth in key segments like gastroenterology and aesthetics to drive long-term shareholder value.
View full company profileTherapeutic Areas
Other Hepatic Encephalopathy Drugs
| Drug | Company | Phase |
|---|---|---|
| Rifamycin SV MMX® | Cosmo Pharmaceuticals | Phase 2 |